-
Circle of Willis Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-07 Nitesh P. Patel MD, Lorenzo Rinaldo MD PhD, Giuseppe Lanzino MD
-
Congenital Absence of Right Coronary Artery Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-07 Shriya Sharma MBBS, Elizabeth Johnson MD, Rohan Goswami MD
-
Outcomes of Acute Respiratory Failure in Patients With Cancer in the United States Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-07 Kiyan Heybati BHSc, Jiawen Deng BHSc, Archis Bhandarkar MD, Fangwen Zhou BHSc, Cameron Zamanian BS, Namrata Arya BS, Mohamad Bydon MD, Philippe R. Bauer MD PhD, Ognjen Gajic MD, Allan J. Walkey MD, Hemang Yadav MBBS
To determine the epidemiological effect-magnitude and outcomes of patients with cancer vs those without cancer who are hospitalized with acute respiratory failure (ARF). We reviewed hospitalizations within the National Inpatient Sample (NIS) database between January 1, 2016, and December 31, 2018. Patients were classified based on a diagnosis of solid-organ cancer, hematologic cancer, or no cancer
-
Emulated Trial for Discharge Prescription of Guideline-Directed Medical Therapy and 15-Year Survival After Coronary Artery Bypass Graft Surgery Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-07 Yaron Moshkovitz MD, Liat Orenstein MSc, Liraz Olmer MSc, Keren Laufer MSc, Arnona Ziv MA, Rachel Dankner MD MPH
To explore admission and discharge prescription rates of guideline-directed medical therapy (GDMT), defined as aggregate antiplatelet agents, statins, and β-blockers, after coronary artery bypass graft (CABG) surgery and to reveal its association with long-term survival. This is a prospective cohort study–based emulated trial of patients undergoing elective or semi-elective isolated CABG surgery in
-
Highlights From the Current Issue – Audiovisual Summary Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 Karl A. Nath MBChB
-
-
-
Heart Failure and Hypertrophic Cardiomyopathy—Looking Back on Decades of Remarkable Progress Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 Yogesh N.V. Reddy MD MSc
-
Floating World by Charles Munch Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 Margaret R. Wentz BA
-
Children’s Author and Cartoonist Dr. Seuss: Not That Kind of Doctor, But a Medical School Bears His Name Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 David P. Steensma MD
-
Older Adults’ Perceptions of Their Risk and Its Correlation With Coronary Atherosclerosis Burden Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 Garshasb Soroosh MD, Zeina Dardari MS, Candace Howard-Claudio MD PhD, Pamela Lutsey PhD MPH, Kunihiro Matsushita MD PhD, Michael Blaha MD MPH
-
Preventing and Responding to Physician Suicide Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 Terry L. Hunt II MD MBA, W. Michael Hooten MD
-
Aortitis Increases Risk of Relapse and Vascular Events in Takayasu Arteritis Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 Alexis F. Guédon MD MPH, Romain Collot MD, Christian Agard MD PhD, Alizée Raimbeau MD, Antoine Bénichou MD, Jérôme Connault MD, Arsène Mekinian MD PhD, Olivier Espitia MD PhD
-
Management of Patients With Kidney Disease Undergoing Bariatric Surgery: A Multidisciplinary Approach Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 Aleksandra Kukla MD, Yogish C. Kudva MD, Pavel Navratil MD, Sukhdeep S. Sahi MBBS, Roberto P. Benzo MD, David C. Fipps DO, Avery E. Erickson MS RDN LD CLC, Rachael R. Majorowicz RDN CSR LD, Matthew M. Clark PhD, Carrie A. Schinstock MD, Pankaj Shah MD, Meera Shah MB ChB, Tayyab S. Diwan MD
Bariatric surgery is increasingly recognized as a safe and effective treatment for obesity in patients with chronic kidney disease (CKD), including stages 4, 5, and 5D (on dialysis). Among the available surgical methods, sleeve gastrectomy (SG) is the most commonly performed weight loss procedure and is mainly done to facilitate kidney transplantation (KT). However, many KT candidates treated with
-
The Importance of Estimating Excess Deaths Regionally During the COVID-19 Pandemic Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 Suzette J. Bielinski PhD, Sheila M. Manemann MPH, Guilherme S. Lopes PhD, Ruoxiang Jiang BSc, Susan A. Weston MS, R. Ross Reichard MD, Aaron D. Norman MPH, Celine M. Vachon PhD, Paul Y. Takahashi MD MPH, Mandeep Singh MD, Nicholas B. Larson PhD, Véronique L. Roger MD MPH, Jennifer L. St. Sauver PhD
National or statewide estimates of excess deaths have limited value to understanding the impact of the COVID-19 pandemic regionally. We assessed excess deaths in a 9-county geographically defined population that had low rates of COVID-19 and widescale availability of testing early in the pandemic, well-annotated clinical data, and coverage by 2 medical examiner’s offices. We compared mortality rates
-
Oncocytic Poorly Differentiated Thyroid Carcinoma Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 Rumeal D. Whaley MD, Sounak Gupta MBBS PhD, Lori A. Erickson MD
-
A Giant Subacute Aortic Valve Thrombus Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 Mariama Akodad MD PhD, Philippe Rouviere MD, Richard Gervasoni MD
-
Adrenal Hemorrhage: A Comprehensive Analysis of a Heterogeneous Entity—Etiology, Presentation, Management, and Outcomes Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 Prerna Dogra MBBS, Mrunal Chinthapalli MBBS, Rashi Sandooja MBBS, Leili Rahimi MD, Nicole M. Iniguez-Ariza MD, Trenton Foster MD, Irina Bancos MD
To investigate the etiology, presentation, management, and outcomes of patients with adrenal hemorrhage (AH). Longitudinal study of consecutive adult patients with radiologically confirmed AH (January 1, 2017, through December 31, 2021). Of the 363 patients with AH (median age, 62 years [interquartile range (IQR, 52-70 years]; 128 women [35%]), 338 (93%) had unilateral AH and 25 (7%) had bilateral
-
Evolution and Prognostic Significance of Patient-Reported Symptoms After Intervention in Severe Aortic Stenosis Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 J. Alberto San Román MD, Cristina Ybarra-Falcón MD, Mario García-Gómez MD, Noemí Ramos MD, Luis Nombela MD PhD, Manuel Carnero MD, Ignacio J. Amat-Santos MD PhD, Teresa Sevilla MD, Ana Revilla MD, Manuel Carrasco MD, Javier López-Díaz MD, Isidre Vilacosta MD
To describe the evolution of symptoms in patients with symptomatic severe aortic stenosis (sSAS) undergoing valve replacement, the predictors of the persistence of these symptoms, and their prognostic significance. The evolution of symptoms after intervention in sSAS and their association with outcome are unknown. Data from patients with sSAS who underwent intervention were collected. All-cause mortality
-
Acitretin Treatment Improves a Case of Severe Generalized Epidermodysplasia Verruciformis Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 Jun-Cheng Liu MM, Si-Tan Dong MM, Dong-Mei Shi MD PhD
-
Chronic Granulomatous Disease Presenting With Recurrent Skin Infections Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 Ryan B. Khodadadi MD, Zachary A. Yetmar MD, Carmen M. Montagnon MD
-
Building Capacity for Pragmatic Trials of Digital Technology in Primary Care Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 David R. Rushlow MD, Thomas D. Thacher MD, Barbara A. Barry PhD
Frontline primary care teams face important challenges in seeking to transform the quality of care delivered to patients and to reduce clerical burden for clinicians. Digital technologies using artificial intelligence hold substantial promise to aid in this transformation. Both pragmatic clinical trials and implementation science are key tools to successfully introduce, evaluate, and sustain innovations
-
Academic Promotions in Medicine: An Appraisal of Fairness Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-03-01 Rahma Warsame MD, Yong-hun Kim, Melody Y. Ouk M. Ed., Kristin C. Mara MS, Martha Q. Lacy MD, Sharonne N. Hayes MD, Zamzam Shalle, Joyce Balls-Berry PhD, Barbara L. Jordan, Felicity T. Enders PhD, Alexandra P. Wolanskyj-Spinner MD, Robert J. Spinner MD
To investigate whether the process of conferring academic rank or components of the promotion packet contribute to the lack of parity in academic advancement for women and individuals underrepresented in medicine (URMs). We retrospectively reviewed prospective promotion applications to the position of associate professor or professor at Mayo Clinic from January 2, 2015, through July 1, 2019. Individuals
-
34-Year-Old Man With Sudden Epigastric Abdominal Pain Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-06 Caroline G. Olson, Christian Karime, Razvan Chirila
-
55-Year-Old Woman With Acute Progressive Dyspnea Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-06 Manfred M. Kubler MD, Anthony H. Kashou MD, Nandan S. Anavekar MB BCh
-
Degree of Risk Factor Control and Incident Cardiovascular Diseases in Patients With Hypertension Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-06 Minghao Kou MHS, Xuan Wang MD PhD, Hao Ma MD PhD, Xiang Li MD PhD, Yoriko Heianza PhD RD, Lu Qi MD PhD
To investigate whether joint risk factor control could reduce the excess risk of cardiovascular disease (CVD) in patients with hypertension. A total of 75,293 patients with diagnosed hypertension from the UK Biobank study were included, matched with 256,619 nonhypertensive controls, and followed up until May 31, 2021. Seven risk factors were measured to define joint risk factor control, including blood
-
40-Year-Old Woman Presenting With Heartburn Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-06 Lauren Loeb, Andree H. Koop
Abstract not available
-
79-Year-Old Man With Massive Hemoptysis Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-06 Danielle M. Shilling MD, Amy N. Montgomery MD MPH, Regina M. Mackey MD
Abstract not available
-
59-Year-Old Man With Abdominal Pain Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-06 Hasan Saleh MD, Nanjiba Nawaz MD, Maoyin Pang MD PhD
Abstract not available
-
Re-evaluating the Incidence and Prevalence of Clinical Hypertrophic Cardiomyopathy: An Epidemiological Study of Olmsted County, Minnesota Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-06 Shahid Karim MBChB MRCP, C. Anwar A. Chahal MBChB MRCP PhD, Akil A. Sherif MBBS, Mohammed Y. Khanji MBChB MRCP PhD, Christopher G. Scott MS, Alanna M. Chamberlain PhD, Jeffrey B. Geske MD, Steve R. Ommen MD, Bernard J. Gersh MBChB DPhil, Virend K. Somers MD PhD, Peter A. Brady MD, Grace Lin MD
To contemporaneously reappraise the incidence-rate, prevalence, and natural history of hypertrophic cardiomyopathy (HCM) in Olmsted County, Minnesota, from 1984 to 2015. A validated medical-record linkage system collecting information for residents of Olmsted County was used to identify all cases of HCM between January 1, 1984, and December 31, 2015. After adjudication of records from Mayo Clinic and
-
Older Tissue Age Derived From Abdominal Computed Tomography Biomarkers of Muscle, Fat, and Bone Is Associated With Chronic Conditions and Higher Mortality Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-02 Andrew D. Rule, Brandon R. Grossardt, Alexander D. Weston, Hillary W. Garner, Timothy L. Kline, Alanna M. Chamberlain, Alina M. Allen, Bradley J. Erickson, Walter A. Rocca, Jennifer L. St. Sauver
To determine whether body composition derived from medical imaging may be useful for assessing biologic age at the tissue level because people of the same chronologic age may vary with respect to their biologic age. We identified an age- and sex-stratified cohort of 4900 persons with an abdominal computed tomography scan from January 1, 2010, to December 31, 2020, who were 20 to 89 years old and representative
-
Clinicopathologic Characteristics, Etiologies, and Outcome of Secondary Oxalate Nephropathy Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-02 Samih H. Nasr, Anthony M. Valeri, Samar M. Said, Sanjeev Sethi, Karl A. Nath, John C. Lieske, Lihong Bu
To report the clinicopathologic characteristics, prognostic indicators, prognosis, and transplant outcome of secondary oxalate nephropathy (ON). We performed a retrospective analysis of 113 consecutive patients with secondary ON diagnosed at Mayo Clinic in Rochester, Minnesota, between January 1, 2001, and March 1, 2023. The incidence of secondary ON among all native biopsies from Mayo Clinic patients
-
Inorganic Nitrates for HFpEF: Is the Juice Worth the Squeeze? Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 Bharathi Upadhya, Dalane W. Kitzman
Abstract not available
-
-
Clinical Trials for Special Populations: Children, Older Adults, and Rare Diseases Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 Robert M. Jacobson, Robert J. Pignolo, Konstantinos N. Lazaridis
Research cannot maximize population health unless it improves health for all members of the public, including special populations such as children, older adults, and people living with rare diseases. Each of these categories require special considerations when planning and performing clinical trials, and common threads of ethical conduct of research in vulnerable populations appear throughout. In this
-
Pseudomonas aeruginosa–Associated Ecthyma Gangrenosum: A Classic Presentation Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 Jack W. McHugh, Julia S. Lehman, Aditya Shah
Abstract not available
-
Genotype Influences Mavacamten Responsiveness in Obstructive Hypertrophic Cardiomyopathy Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 John R. Giudicessi, Said Alsidawi, Jeffrey B. Geske, Darrell B. Newman, Adelaide M. Arruda-Olson, J. Martijn Bos, Steve R. Ommen, Michael J. Ackerman
Abstract not available
-
22-Year-Old Man With Seizures Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 Priscilla Koirala, Reema K. Tawfiq, David Raslau
Abstract not available
-
-
-
In the Limelight: February 2024 Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 Karl A. Nath
Abstract not available
-
Cardiotoxicity Risk of Cancer Treatment in Patients With Underlying Cardiomyopathies: Is Hypertrophic Cardiomyopathy Any Different? Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 Muhannad Aboud Abbasi, Edward El-Am, Jeffrey B. Geske, Joerg Herrmann
Abstract not available
-
A Platform and Roadmap for Tissue Biorepositories Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 Richard G. Ellenbogen
Abstract not available
-
Mycobacterium marinum Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 Hannah B. Haberecht, Deborah B. Cull, Carilyn N. Wieland
Abstract not available
-
Scholarly Debate About Drug Efficacy in Scientific Journals Is “Protected Speech,” Not Libel Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 Evan D. Kharasch, Paul B. Klaas, William L. Lanier
Abstract not available
-
From the Operating Room to the Laboratory: Role of the Neuroscience Tissue Biorepository in the Clinical, Translational, and Basic Science Research Pipeline Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 Alfredo Quiñones-Hinojosa, Aleeshba Basil, Diogo Moniz-Garcia, Paola Suarez-Meade, Andres Ramos, Mark Jentoft, Erik Middlebrooks, Sanjeet Grewal, Kingsley Abode-Iyamah, Mohamad Bydon, Jann Sarkaria, Dennis Dickson, Kristin Swanson, Steven Rosenfeld, Paula Schiapparelli, Hugo Guerrero-Cazares, Kaisorn Chaichana, Fredric Meyer
Objective To establish a neurologic disorder–driven biospecimen repository to bridge the operating room with the basic science laboratory and to generate a feedback cycle of increased institutional and national collaborations, federal funding, and human clinical trials. Methods Patients were prospectively enrolled from April 2017 to July 2022. Tissue, blood, cerebrospinal fluid, bone marrow aspirate
-
Temporal Association Between Vaping and Risk of Cardiac Events Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 Sahej Bains, Ramin Garmany, Raquel Neves, John R. Giudicessi, Xiaozhi Gao, David J. Tester, J. Martijn Bos, Michael J. Ackerman
Objective To describe our early observations with sudden cardiac arrest (SCA) and sudden death (SD) in patients using vape products. Patients and Methods A retrospective analysis of Mayo Clinic’s Windland Smith Rice Genetic Heart Rhythm Clinic and Sudden Death Genomics Laboratory was performed on all SCA survivors and decedents who presented between January 1, 2007, and December 31, 2021, to identify
-
Machine Learning for Diagnosis of Pulmonary Hypertension by Echocardiography Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 Vidhu Anand, Alexander D. Weston, Christopher G. Scott, Garvan C. Kane, Patricia A. Pellikka, Rickey E. Carter
Objective To evaluate a machine learning (ML)–based model for pulmonary hypertension (PH) prediction using measurements and impressions made during echocardiography. Methods A total of 7853 consecutive patients with right-sided heart catheterization and transthoracic echocardiography performed within 1 week from January 1, 2012, through December 31, 2019, were included. The data were split into training
-
Scleromyxedema and Underlying Multiple Myeloma Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 Shruti Agrawal, Nelson Leung, Lisa Drage
Abstract not available
-
Sporadic Prostate Cancer in a Patient With Lynch Syndrome Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 Ameya Patil, Lori A. Erickson, Sounak Gupta
Abstract not available
-
“Title Unknown” by Gary Ernest Smith Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 Margaret R. Wentz
Art is integrated into the Mayo Clinic environment. Since the original Mayo Clinic Building was finished in 1914, many pieces have been donated or commissioned for patients and staff to enjoy. Each issue of Mayo Clinic Proceedings features a work of art (as interpreted by the author) that is displayed in a building or on the grounds of Mayo Clinic campuses. Download : Download high-res image (1MB)
-
Highlights From the Current Issue – Audiovisual Summary Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-02-01 Karl A. Nath
Abstract not available
-
Advances in Screening for Barrett Esophagus and Esophageal Adenocarcinoma Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-01-25 Kornpong Vantanasiri MD, Amrit K. Kamboj MD, John B. Kisiel MD, Prasad G. Iyer MD MSc
Esophageal adenocarcinoma (EAC), the primary form of esophageal cancer in the United States, is a lethal cancer with exponentially increasing incidence. Screening for Barrett esophagus (BE), the only known precursor to EAC, followed by endoscopic surveillance to detect dysplasia and early-stage EAC and subsequent endoscopic treatment (to prevent progression of dysplasia to EAC and to treat early-stage
-
-
Impact of Thyroid Status on Incident Kidney Dysfunction and Chronic Kidney Disease Progression in a Nationally Representative Cohort Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-01-02 Amy S. You, Kamyar Kalantar-Zadeh, Gregory A. Brent, Yoko Narasaki, Andrea Daza, John J. Sim, Csaba P. Kovesdy, Danh V. Nguyen, Connie M. Rhee
Objective To examine the relationship between thyroid status and incident kidney dysfunction/chronic kidney disease (CKD) progression. Patients and Methods We examined incident thyroid status, ascertained by serum thyrotropin (TSH) levels measured from January 1, 2007, through December 31, 2018, among 4,152,830 patients from the Optum Labs Data Warehouse, containing deidentified retrospective administrative
-
36-Year-Old Woman With Progressive Dyspnea, Cough, and Chills Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-01-02 Megan M. Ellis, Nayla Ahmed, Eva M. Carmona
Abstract not available
-
71-Year-Old Man With Progressive Dyspnea on Exertion Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-01-02 Alan W. Hu, Jeremy M. Clain
Abstract not available
-
Misleading Medical Stamps: The 2022 “Monkeypox” Issues Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-01-02 David P. Steensma, Thomas E. Witzig
Abstract not available
-
Industry Payments to Physicians in the United States From 2017 to 2021 and the Impact of the COVID-19 Pandemic Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-01-06 Mihir Khunte, Anthony Zhong, Chris Lee, Xiao Wu, Dheeraj Gandhi, Ajay Malhotra
Abstract not available
-
Hilfiker in Perspective Mayo Clin. Proc. (IF 8.9) Pub Date : 2024-01-06 Matthew Morrell, Ian Sabroe, Chris Millard
Abstract not available